The total return over the past 12 months is -14.69% vs. +16.94% for the S&P 500. So far it's up -5.02% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (14.69%) | (47.55%) | (28.71%) | N/A | N/A | N/A |
| Total Return CAGR | (14.69%) | (47.55%) | (28.71%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cabaletta Bio, Inc. (CABA)
| Year | Start price | End price | CABA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.19 | $2.08 | (5.02%) | +14.51% | (19.53%) |
| 2025 | $2.27 | $2.19 | (3.52%) | +17.72% | (21.24%) |
| 2024 | $22.70 | $2.27 | (90.00%) | +24.89% | (114.89%) |
| 2023 | $9.25 | $22.70 | +145.41% | +26.19% | +119.22% |
| 2022 | $3.79 | $9.25 | +144.06% | (18.17%) | +162.23% |
| 2021 | $12.48 | $3.79 | (69.63%) | +28.74% | (98.37%) |
| 2020 | $13.97 | $12.48 | (10.67%) | +18.37% | (29.04%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
